BioNTech SE - ADR vs Dow Inc — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Dow Inc trades at $31.24 (market cap $22.58B). The key difference: BioNTech SE - ADR and Dow Inc are close in size by market cap, and Dow Inc pays a 4.48% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | DOW | |
|---|---|---|
Market Cap | $23.31B | $22.58B |
Sector | Health | Basic Materials |
52-Week High | $119.34 | $41.87 |
52-Week Low | $83.89 | $20.65 |
Enterprise Value | $6.60B | $38.27B |
Dividend Yield | — | 4.48% |
Trailing returns across standard periods
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →Dow Inc is a diversified chemical manufacturing company. It combining science and technology to develop innovative solutions that are essential to human progress. Dow's portfolio is comprised of six global business units, organized into three operating segments: Packaging & Specialty Plastics, Industrial Intermediates & Infrastructure, and Performance Materials & Coatings.
Read more on DOW →